McEnany Patrick J (CIK 0000929985)

Latest company ownership

Shares held
4,373,477
Last filed at
Dec 3, 2025
Confidence Score
48.3
2025Q4
Confidence Score History
2012Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 6, 2025 Jun 10, 2025 CATALYST PHARMACEUTICALS, INC. Director Sell 16.3 -200,000 -4.46% ✗ $5.2M
Nov 19, 2024 Nov 21, 2024 CATALYST PHARMACEUTICALS, INC. Director Sell 17.5 -170,845 -1.87% ✗ $3.6M
Nov 13, 2024 Nov 15, 2024 CATALYST PHARMACEUTICALS, INC. Director Sell 17.5 -137,155 -1.51% ✗ $3.1M
Nov 11, 2024 Nov 13, 2024 CATALYST PHARMACEUTICALS, INC. Director Sell 15.0 -492,000 -3.53% ✗ $11.5M
May 15, 2023 May 17, 2023 CATALYST PHARMACEUTICALS, INC. CEO Sell 42.5 -26,151 -0.66% ✗ $346K
Nov 18, 2022 Nov 22, 2022 CATALYST PHARMACEUTICALS, INC. CEO Sell 16.3 -500,000 -6.02% ✗ $7.8M
Sep 13, 2022 Sep 15, 2022 CATALYST PHARMACEUTICALS, INC. CEO Sell 15.0 -1,027,611 -20.84% ✗ $15.8M
Aug 18, 2022 Aug 19, 2022 CATALYST PHARMACEUTICALS, INC. CEO Sell 37.5 -300,000 -1.20% ✗ $4.2M
Aug 20, 2021 Aug 24, 2021 CATALYST PHARMACEUTICALS, INC. CEO Sell 40.0 -136,778 -1.38% ✗ $763.6K
Aug 13, 2021 Aug 17, 2021 CATALYST PHARMACEUTICALS, INC. CEO Sell 40.0 -62,715 -1.28% ✗ $384.1K
Sep 30, 2020 Sep 30, 2020 CATALYST PHARMACEUTICALS, INC. CEO Buy 61.3 +15,000 0.31% ✗ $44.6K
Oct 3, 2019 Oct 3, 2019 CATALYST PHARMACEUTICALS, INC. CEO Buy 61.3 +10,000 0.21% ✗ $48.9K
Jun 11, 2019 Jun 11, 2019 CATALYST PHARMACEUTICALS, INC. CEO Buy 72.5 +25,000 0.53% ✗ $80.8K
Dec 19, 2018 Dec 19, 2018 CATALYST PHARMACEUTICALS, INC. CEO Buy 61.3 +20,000 0.42% ✗ $44.8K
Apr 3, 2018 Apr 3, 2018 CATALYST PHARMACEUTICALS, INC. CEO Buy 61.3 +20,000 0.43% ✗ $45.8K
Sep 5, 2017 Sep 5, 2017 CATALYST PHARMACEUTICALS, INC. CEO Buy 65.0 +20,000 0.45% ✗ $51.6K
Jun 14, 2016 Jun 14, 2016 CATALYST PHARMACEUTICALS, INC. CEO Buy 82.5 +105,300 2.46% ✗ $68.5K
Apr 26, 2016 Apr 26, 2016 CATALYST PHARMACEUTICALS, INC. CEO Buy 78.8 +50,000 1.18% ✗ $32.4K
Dec 28, 2015 Dec 28, 2015 CATALYST PHARMACEUTICALS, INC. CEO Buy 72.5 +25,000 0.59% ✗ $59.7K
Oct 1, 2015 Oct 1, 2015 CATALYST PHARMACEUTICALS, INC. CEO Buy 61.3 +10,000 0.24% ✗ $28.1K
Apr 27, 2015 Apr 27, 2015 CATALYST PHARMACEUTICALS, INC. CEO Buy 56.3 +5,000 0.12% ✗ $19K
Jan 8, 2015 Jan 8, 2015 CATALYST PHARMACEUTICALS, INC. CEO Buy 82.5 +50,000 1.28% ✗ $139.8K
May 21, 2014 May 21, 2014 CATALYST PHARMACEUTICALS, INC. CEO Buy 68.8 +25,000 0.66% ✗ $47.2K
Feb 7, 2014 Feb 7, 2014 CATALYST PHARMACEUTICALS, INC. CEO Buy 68.8 +25,000 0.67% ✗ $45.5K
Oct 21, 2013 Oct 21, 2013 CATALYST PHARMACEUTICALS, INC. CEO Buy 82.5 +50,000 1.35% ✗ $79.7K
Feb 19, 2013 Feb 20, 2013 CATALYST PHARMACEUTICALS, INC. CEO Buy 78.8 +50,000 1.37% ✗ $23K
Dec 17, 2012 Dec 18, 2012 CATALYST PHARMACEUTICALS, INC. CEO Buy 83.8 +100,000 2.86% ✗ $44.5K
Nov 15, 2012 Nov 15, 2012 CATALYST PHARMACEUTICALS, INC. CEO Buy 83.8 +100,000 2.94% ✗ $42K
Jul 2, 2012 Jul 3, 2012 CATALYST PHARMACEUTICALS, INC. CEO Buy 68.8 +31,200 0.93% ✗ $16.8K
May 30, 2012 May 31, 2012 CATALYST PHARMACEUTICALS, INC. CEO Buy 60.0 +10,000 0.30% ✗ $5.8K
May 24, 2012 May 29, 2012 CATALYST PHARMACEUTICALS, INC. CEO Buy 68.8 +31,250 0.94% ✗ $25K